Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer

Clinical trial NCT05866510 · UNKNOWN

Trial details

NCT number: NCT05866510
Sponsor: Peking University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2023-05-15
Primary completion: 2024-04-30
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.